"Treatment Use of ECMO In Pregnancy or Peripartum Patient."
1 other identifier
observational
5
1 country
1
Brief Summary
The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2019
CompletedStudy Start
First participant enrolled
October 28, 2019
CompletedFirst Posted
Study publicly available on registry
October 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedNovember 23, 2020
November 1, 2020
5 months
October 28, 2019
November 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Outcome of Mother
Describe clinical course of pregnant or recently postpartum patients with cardiogenic shock treated with ECMO, including the rate of neonate survival
Time of diagnosis -Six Month Survival Rate
Study Arms (1)
Cardiogenic Shock Treated with ECMO
This cohort of participants required clinical intervention with ECMO for treatment of their index cardiogenic shock episode while pregnant or post delivery of their infant.
Interventions
Use of ECMO for circulatory / hemodynamic support of peripartum of pregnant patients who developed cardiogenic shock.
Eligibility Criteria
Women treated with ECMO while pregnant or immediately postpartum (within six months).
You may qualify if:
- Female
- Age 18 years or greater at the time of ECMO treatment.
- Pregnant or within 6 months post-partum at the time of ECMO cannulation
You may not qualify if:
- No history of pregnancy.
- No treatment with ECMO.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sarah Thordsenlead
- Medical College of Wisconsincollaborator
Study Sites (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Thordsen, MD
Medical College of Wisconsin
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor Cardiovascular Medicine
Study Record Dates
First Submitted
October 28, 2019
First Posted
October 30, 2019
Study Start
October 28, 2019
Primary Completion
March 31, 2020
Study Completion
March 31, 2020
Last Updated
November 23, 2020
Record last verified: 2020-11